Meru is commercializing a novel biotech research instrument and consumables. The methodology is more sensitive, more accurate, more versatile and less expensive than anything on the market today. The initial market will be the $450M label free drug discovery tools market but the tech enables access many applied markets. We have spent 3 years improving on the original academic development and are nearing a preproduction model for field testing.